Clinical Trial Update: AKY15-HK-301_NEPA Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for AKY15-HK-301_NEPA in breast cancer, sponsored by The Chinese University of Hong Kong, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AKY15-HK-301_NEPA

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING